Clinical Trial Update: Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating weekly gemcitabine, epirubicin, and docetaxel in locally advanced or inflammatory breast cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-21